Similarly, CXCL8 was found to be elevated in DN patients and diabetic mice, and treatment with a CXCL8-specific antagonist improved histological and functional parameters related to DN development in murine diabetic models56,57. Here, CXCL8 is linked to liver dysplastic nodule.